- High gross margin of 75.1%
- Strong operating margin of 29.9%
- Low bankruptcy risk (Altman Z-Score: 3.41)
Novartis AG stock upgraded from Sell Candidate to Hold/Accumulate after Monday trading session
(Updated on Jun 22, 2026)
The Novartis AG stock price fell by -2.77% on the last day (Monday, 22nd Jun 2026) from $145.00 to $140.99. During the last trading day the stock fluctuated 0% from a day low at $140.99 to a day high of $140.99. The price has been going up and down for this period, and there has been a -2.01% loss for the last 2 weeks. Volume has increased on the last day by 306 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 306 shares were bought and sold for approximately $43.14 thousand.
The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.96% during the next 3 months and, with a 90% probability hold a price between $127.13 and $137.67 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
NVSEF Signals & Forecast
There are few to no technical positive signals at the moment. The Novartis AG stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $144.24 and $144.65. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -6.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Novartis AG gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Novartis AG stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0.452%.
Our recommended stop-loss: $135.69 (-3.76%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 17 days ago.)
Trading Expectations (NVSEF) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect Novartis AG to open at $140.99, and during the day (based on 14 day Average True Range), to move between $140.12 and $141.86, which gives a possible trading interval of +/-$1.74 (+/-1.24%) up or down from last closing price. If Novartis AG takes out the full calculated possible swing range there will be an estimated 1.24% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $144.14, some $3.14 (2.23%) from the current price of $140.99, our system finds the risk reward not very attractive.
Is Novartis AG stock A Buy?
Novartis AG holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
0.000
Hold/Accumulate
Upgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on June 23, 2026 - $140.99 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NVSEF Performance
Trading levels for NVSEF
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 140.99 | - |
| R2 | 140.99 | - |
| R1 | 140.99 | - |
| Price | 140.99 | |
| S1 | 140.99 | - |
| S2 | 140.99 | - |
| S3 | 140.99 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 154.85 | 9.83% |
| R2 | 150.00 | 6.39% |
| R1 | 144.14 | 2.23% |
| Price | 140.99 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
NVSEF Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 05, 2026 | Mar 11, 2026 | Mar 12, 2026 | $4.82 | 3.03% |
| 2 | Mar 10, 2026 | Mar 10, 2026 | Mar 12, 2026 | $4.75 | 3.11% |
| 3 | Jan 31, 2025 | Mar 12, 2025 | Mar 13, 2025 | $3.98 | 3.65% |
| 4 | Mar 11, 2025 | Mar 11, 2025 | Mar 13, 2025 | $3.84 | 3.52% |
| 5 | Mar 07, 2024 | Mar 07, 2024 | Mar 11, 2024 | $3.83 | 3.88% |
FAQ
Click here for our free guide on how to buy Novartis AG Stock.
Buy NVSEF